What does APOTHEEK OOIGEM do?

APOTHEEK OOIGEM is a pharmacy in Wielsbeke. Public Limited, started on 24 January 1987, 1 establishment.

What is the address of APOTHEEK OOIGEM?

The registered office of APOTHEEK OOIGEM is located at Oostrozebeeksestraat(O) 8, 8710 Wielsbeke.

Is APOTHEEK OOIGEM still active?

Yes. According to the CBE (29 October 2026) APOTHEEK OOIGEM is active, legal situation “Normale toestand”, started on 24 January 1987.

Is APOTHEEK OOIGEM registered on Peppol?

Yes, APOTHEEK OOIGEM is registered on the Peppol network with ID 0208:0430360195.

What is the enterprise number of APOTHEEK OOIGEM?

The enterprise number of APOTHEEK OOIGEM is BE0430360195.

When was APOTHEEK OOIGEM founded?

APOTHEEK OOIGEM was founded on 24 January 1987.

Who are the directors of APOTHEEK OOIGEM?

According to the 2025 annual accounts, the directors of APOTHEEK OOIGEM are: CROSSVER BV.

Is APOTHEEK OOIGEM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 January 1987; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK OOIGEM make in 2025?

APOTHEEK OOIGEM posted a profit after taxes of € 105,073 in financial year 2025.

What is the revenue of APOTHEEK OOIGEM?

As a small company, APOTHEEK OOIGEM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 291,803.

How much does an employee at APOTHEEK OOIGEM earn?

The average wage cost per full-time employee at APOTHEEK OOIGEM was € 75,500 in 2025: staff costs of € 143,533 for 1.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK OOIGEM have?

According to the 2025 annual accounts, APOTHEEK OOIGEM has 1.9 full-time equivalents (FTE).

APOTHEEK OOIGEM (Public Limited) - Wielsbeke

Dossier APOTHEEK OOIGEM, printed on 29 October 2026 from databakkes.be/en/0430360195/apotheek-ooigem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK OOIGEM from Wielsbeke, company number BE0430360195, closed financial year 2025 with a result of € 105,073 after tax. For that financial year APOTHEEK OOIGEM recorded a gross margin of € 291,803 and equity of € 338,664. Compared with financial year 2024, the result moved from € 117,534 to € 105,073. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Growing

€ 338,664

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 105,073

▼ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 690,925

▲ € 551,294 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 103,000 paid out

98 % of the profit went to the shareholders, mostly to CROSSVER (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.9

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 143,533

▲ 5% vs 2024

€ 75,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,176

▲ € 1,670 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 426

▼ € 105,019 vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 122,919

▲ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,187

▲ 18% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 266,847 Gross margin 2022: € 266,847 First fiscal year in the series	€ 272,811 Gross margin 2023: € 272,811 ▲ 2% vs 2022 (€ 266,847) Favourable step	€ 280,667 Gross margin 2024: € 280,667 ▲ 3% vs 2023 (€ 272,811) Favourable step	€ 291,803 Gross margin 2025: € 291,803 ▲ 4% vs 2024 (€ 280,667) Favourable step	▲ 4%
Profit after taxes	€ 131,779 Profit after taxes 2022: € 131,779 First fiscal year in the series	€ 126,534 Profit after taxes 2023: € 126,534 ▼ 4% vs 2022 (€ 131,779) Unfavourable step	€ 117,534 Profit after taxes 2024: € 117,534 ▼ 7% vs 2023 (€ 126,534) Unfavourable step	€ 105,073 Profit after taxes 2025: € 105,073 ▼ 11% vs 2024 (€ 117,534) Unfavourable step	▼ 11%
Equity	€ 332,023 Equity 2022: € 332,023 First fiscal year in the series	€ 335,057 Equity 2023: € 335,057 ▲ 1% vs 2022 (€ 332,023) Favourable step	€ 336,591 Equity 2024: € 336,591 Unchanged (€ 335,057) Favourable step	€ 338,664 Equity 2025: € 338,664 ▲ 1% vs 2024 (€ 336,591) Favourable step	▲ 1%
Total debts	€ 413,384 Total debts 2022: € 413,384 First fiscal year in the series	€ 388,560 Total debts 2023: € 388,560 ▼ 6% vs 2022 (€ 413,384) Favourable step	€ 469,880 Total debts 2024: € 469,880 ▲ 21% vs 2023 (€ 388,560) Unfavourable step	€ 1,017,393 Total debts 2025: € 1,017,393 ▲ 117% vs 2024 (€ 469,880) Unfavourable step	▲ 117%
Cash	€ 103,546 Cash 2022: € 103,546 First fiscal year in the series	€ 61,915 Cash 2023: € 61,915 ▼ 40% vs 2022 (€ 103,546) Unfavourable step	€ 139,631 Cash 2024: € 139,631 ▲ 126% vs 2023 (€ 61,915) Favourable step	€ 690,925 Cash 2025: € 690,925 ▲ € 551,294 vs 2024 (€ 139,631) Favourable step	▲ € 551,294
Land & buildings	€ 183,805 Land & buildings 2022: € 183,805 First fiscal year in the series	€ 191,147 Land & buildings 2023: € 191,147 ▲ 4% vs 2022 (€ 183,805) Unchanged	€ 183,900 Land & buildings 2024: € 183,900 ▼ 4% vs 2023 (€ 191,147) Unchanged	€ 175,299 Land & buildings 2025: € 175,299 ▼ 5% vs 2024 (€ 183,900) Unchanged	▼ 5%
Retained profit	€ 65,889 Retained profit 2022: € 65,889 First fiscal year in the series	€ 68,923 Retained profit 2023: € 68,923 ▲ 5% vs 2022 (€ 65,889) Favourable step	€ 70,458 Retained profit 2024: € 70,458 ▲ 2% vs 2023 (€ 68,923) Favourable step	€ 72,531 Retained profit 2025: € 72,531 ▲ 3% vs 2024 (€ 70,458) Favourable step	▲ 3%
Dividend	€ 128,000 Dividend 2022: € 128,000 First fiscal year in the series	€ 123,500 Dividend 2023: € 123,500 ▼ 4% vs 2022 (€ 128,000) Unchanged	€ 116,000 Dividend 2024: € 116,000 ▼ 6% vs 2023 (€ 123,500) Unchanged	€ 103,000 Dividend 2025: € 103,000 ▼ 11% vs 2024 (€ 116,000) Unchanged	▼ 11%
Bank debt	€ 70,000 Bank debt 2022: € 70,000 First fiscal year in the series	€ 50,291 Bank debt 2023: € 50,291 ▼ 28% vs 2022 (€ 70,000) Favourable step	€ 105,445 Bank debt 2024: € 105,445 ▲ 110% vs 2023 (€ 50,291) Unfavourable step	€ 426 Bank debt 2025: € 426 ▼ € 105,019 vs 2024 (€ 105,445) Favourable step	▼ € 105,019
Balance sheet total	€ 745,407 Balance sheet total 2022: € 745,407 First fiscal year in the series	€ 723,617 Balance sheet total 2023: € 723,617 ▼ 3% vs 2022 (€ 745,407) Unchanged	€ 806,471 Balance sheet total 2024: € 806,471 ▲ 11% vs 2023 (€ 723,617) Unchanged	€ 1,356,057 Balance sheet total 2025: € 1,356,057 ▲ 68% vs 2024 (€ 806,471) Unchanged	▲ 68%
Employees (FTE)	1.9 Employees (FTE) 2022: 1.9 First fiscal year in the series	1.9 Employees (FTE) 2023: 1.9 Unchanged (1.9) Unchanged	1.9 Employees (FTE) 2024: 1.9 Unchanged (1.9) Unchanged	1.9 Employees (FTE) 2025: 1.9 Unchanged (1.9) Unchanged

Key figures of APOTHEEK OOIGEM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK OOIGEM?

What happened at APOTHEEK OOIGEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 CROSSVER BV stepped down as director. NBB
Jul 8, 2026 New annual accounts for financial year 2025: profit of € 105,073 (▼ 11% vs 2024). Source: NBB ↗
2014 CROSSVER BV became a director. NBB
Feb 23, 1987 New establishment in Wielsbeke. KBO
Jan 24, 1987 Start of the company according to the CBE. KBO

In short

From € 131,779 profit in 2022 to € 105,073 profit in 2025.

Paid € 5,372 in corporate taxes since 2022.

Best year ever: 2022, with € 131,779 profit.

On average € 153,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

CROSSVER 100%

The stake of CROSSVER comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK OOIGEM

The shares are held by CROSSVER (100%).

Directors

According to the 2025 annual accounts

CROSSVER BV

Director · represented by Lambrecht Valentine

Also active at: APOTHEEK STORME

since 2014 · until 2029

Shareholders

CROSSVER

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Oostrozebeeksestraat(O) 8

8710 Wielsbeke

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CROSSVER same network

€ 195,543 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0430.360.195

VAT number

BE 0430.360.195

Registered office

Oostrozebeeksestraat(O) 8, 8710 Wielsbeke

Names & denominations

APOTHEEK OOIGEM

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

24 January 1987

Peppol

Active · Active since 28 Oct 2024

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK OOIGEM

Financials

What happened to APOTHEEK OOIGEM?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions